ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NGM Biopharmaceuticals, Inc · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
breast-cancercervical-cancergastric-cancernon-small-cell-lung-cancerovarian-cancerpancreatic-cancerrenal-cell-carcinoma
pancreatic cancer, breast cancer, gastric cancer, non-small cell lung cancer, cervical cancer, endocervical cancer, squamous cell carcinoma of head and neck, bladder urothelial cancer, colorectal carcinoma, esophageal cancer, ovarian cancer, renal cell carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 824951
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.